Non-muscle myosin IIB (Myh10) is required for epicardial function and coronary vessel formation during mammalian

Liam A Ridge1, Karen Mitchell1, Ali Al-Anbaki1

  • 1Division of Evolution and Genome Sciences, School of Biological Sciences, Faculty of Biology, Medicine, and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom.

Plos Genetics
|October 31, 2017
PubMed

Insights

A mutation in the Myh10 gene disrupts cardiac development and coronary vessel formation in mice. This study highlights the crucial role of NMHC IIB in embryonic survival and cardiovascular health.

Area of Science:

  • Cardiovascular Biology
  • Developmental Biology
  • Genetics

Background:

  • Coronary vasculature is vital for heart function; disruptions cause cardiac disease.
  • Understanding coronary vessel development is key to treating cardiovascular disease.
  • Myosin IIB (NMHC IIB) plays a role in cellular processes.

Purpose of the Study:

  • Investigate the role of NMHC IIB in embryonic cardiac development and coronary vasculature formation.
  • Characterize cardiac defects in a novel mouse mutant (EHC) with a Myh10 splice site mutation.

Main Methods:

  • ENU mutagenesis screen to identify mutants.
  • Positional cloning and candidate gene analysis to identify the causative mutation.
  • Phenotypic characterization of cardiac and coronary vessel development in mutant embryos.

Main Results:

  • Identified a point mutation in the Myh10 gene (encoding NMHC IIB) causing embryonic hydrocephalus and cardiac defects (EHC).
  • EHC mutant hearts show myocardial and coronary vasculature abnormalities.
  • Defects in epicardial cell morphology, epithelial-mesenchymal transition (EMT), and epicardial-derived cell (EPDC) migration were observed.

Conclusions:

  • NMHC IIB is essential for proper epicardial cell function.
  • NMHC IIB is required for coronary vessel formation during embryonic development.
  • This study underscores the importance of NMHC IIB in cardiac development and embryonic survival.

Related Concept Videos

Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
252
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
917
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
759
Vaccinations01:51

Vaccinations

Overview
51.1K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K